Chief Executive Officer
Chief Financial Officer
Director of Operations
VP, Innovation and Development
Director of Product Management
Chief Scientific Officer - Europe
Chief Executive Officer
Dan Klevisha is an experienced executive with a demonstrated history of success in technology-based businesses. He is a high-performance commercially driven executive with a track record of transforming technical innovation to commercial success. Dan excels at building teams, understanding and applying technology to market needs, and insight into global market dynamics to scale businesses.
Over his career Dan has led businesses from pre-revenue to over $100M in revenue. Previous executive positions with respected companies such as Thermo Fisher, Bruker Optics, and Foss as well as co-founding two entrepreneurial successes with Polychromix and Galaxy Scientific. Dan holds a Bachelor's degree in Electrical Engineering from the University of Wisconsin.
Chief Financial Officer
Alvin brings extensive financial and operational leadership to the company. With a proven track record of driving strategic financial management, operational efficiency, and cross-functional collaboration, Alvin plays a key role in aligning teams to support data-driven decision-making. Before joining Pion, Alvin held executive finance and operations roles at several industry-leading companies, including AAFCPAs, Delphi Technology Inc., Kidde-Fenwal Inc., Biogen Idec Inc., and Merck & Co. Inc.
Director of Operations
Since joining Pion in 2016, Rob has worked his way up within the ranks because of his commitment and dedication to the company and its values. Prior, he was a Financial Associate for both Prudential and Nationwide Insurance Companies, facilitating the financial and insurance needs for his clients. Rob is also a decorated Veteran having had the honor of serving in the United States Air Force during Operation Desert Shield and Desert Storm. His most valued role came, when he had the opportunity to be a stay-at-home Dad for his twin sons for several years. When Rob is not working, he enjoys spending time with his family. He is also an avid mountain biker and enjoys many outdoors activities.
VP, Innovation and Development
Balint received an M.Sc. in Pharmacy at Semmelweis University in 2007 and a Ph.D. in Pharmaceutical Sciences in 2012. As part of his Ph.D. project, he has developed a skin penetration model that has been licensed and commercialized by Pion Inc. His research interest is focused on the formulation effect on intestinal and skin absorption. In these topics, he has authored or co-authored over 35 research articles in peer-reviewed journals and 1 book chapter. He is an industrial consultant for multiple Ph.D. students at University College London, Semmelweis University, and Budapest University of Technology and Economics. He also holds an honorary associate professor title at Semmelweis University.
Director of Product Management
Shari began her career working as a biochemist at MilliporeSigma, the Life Science business of Merck KGaA, Darmstadt, Germany, building bioanalytical and protein engineering capabilities. Driven by an interest in how products address customer problems, she moved to the business side of science in 2011, holding various roles in field marketing, business development, and product management. After MilliporeSigma, she led product management at Quanterix and at Meso Scale Diagnostics, before joining Pion in 2025. Shari earned her Bachelors in Biochemistry from Rutgers University, a PhD in biophysics from Stony Brook University, and worked as a post-doctoral fellow at MIT.
Chief Scientific Officer - Europe
Karl Box has served as Chief Scientific Officer (Europe) at Pion (UK) since 2020. He is involved in scientific and chemistry related functions within the company, as well as supporting commercial activities and business development. His expertise is in the field of physicochemical measurements, where he has forged a successful career in the development of new instrumentation and assays for supporting drug discovery and development. Karl earned his BSc(Hons) in Chemistry in 1989 from the University of Bath.
Karl is an established speaker at many international scientific meetings and conferences and has contributed to the AAPS eLearning webinar series. He has over 30 peer reviewed publications in scientific journals and has published on many topics, including solubility and lipophilicity and its relationship to the Biopharmaceutical Classification System, and explored the ideas of improving a compounds classification through the use of supersaturation and solubility enhancement strategies, all high-agenda items for the oral biopharmaceutics and drug delivery sectors.